甲胺作为抗癌剂和癌症联合治疗中的辅助剂:目前的进展和未来的前景
Lin Zhu1, Kaiqing Yang1, Zhe Ren1
1Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, PR China.
Translational oncology
|March 31, 2024
概括
甲胺是一种2型糖尿病药物,在癌症治疗中表现有前途. 将甲福明与化疗,放射治疗,向治疗或免疫治疗结合使用,可以增强抗瘤效果和患者的存活率.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 代谢性疾病研究研究
背景情况:
- 甲福明是治疗2型糖尿病的主要抗高血糖药物.
- 最近的研究表明,甲福明具有显著的瘤生长抑制特性.
- 针对癌症的甲胺单一疗法面临限制,包括高剂量要求和狭窄的目标适用性.
研究的目的:
- 审查甲福明与常规抗癌疗法结合的协同抗瘤作用.
- 阐明甲胺联合抗癌活性的潜在机制.
- 更新目前的研究进展和未来在癌症治疗中使用甲胺的前景.
主要方法:
- 对研究的综合文献综述 调查甲福明与化疗,放射疗法,向疗法和免疫疗法的结合.
- 报告的协同抗瘤效应和生存数据的分析.
- 检查了所观察到的治疗效益背后的拟议分子机制.
主要成果:
- 与单一治疗相比,涉及甲胺的组合疗法显示出明显增强的抗瘤效果.
- 接受组合治疗的患者的生存时间更长.
- 不同的常规抗癌策略在与甲胺结合时显示出更好的疗效.
结论:
- 在与传统疗法相结合时,甲胺在癌症治疗中提供了更好的临床效益.
- 这些组合策略已经准备好快速临床转化.
- 在抗瘤策略中需要进一步研究和临床应用甲素.
更多相关视频
10:39Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
13.2K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
196
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
196
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
